Clinical Report: Speech aging may differ across dementia phenotypes
Overview
This study analyzed speech-based aging estimates across various dementia phenotypes in a cohort of 2,928 Spanish-speaking participants. Findings indicate that speech age gaps (SAGs) differ between healthy controls and dementia patients.
Background
Understanding speech aging in dementia may provide insights into cognitive decline and neurodegeneration. This research focuses on speech analysis as a potential biomarker for assessing cognitive health.
Data Highlights
| Group | Speech Age Gap (SAG) |
|---|---|
| Healthy Controls | Lower SAGs |
| Alzheimer's Disease | Larger SAGs |
| Non-Language-Dominant FTD | Larger SAGs |
| Language-Dominant FTD | Largest SAGs |
Key Findings
- Speech age gaps (SAGs) were larger in dementia patients compared to healthy controls.
- Patients with language-dominant frontotemporal dementia (ldFTD) exhibited the largest SAGs.
- Larger SAGs correlated with poorer performance on clinical and cognitive measures.
- Associations between SAGs and plasma p-Tau217 were observed in patients with Alzheimer's disease.
- SAGs showed strong correlations with neuroimaging-derived brain-age gaps.
Clinical Implications
The findings indicate that speech analysis could be a tool for assessing cognitive decline.
Conclusion
This study presents findings on speech-based biomarkers in differentiating dementia phenotypes.
Related Resources & Content
- Nature Medicine, 2025 -- Characterization of Alzheimer’s Disease Phenotypes Using AI from Large-Scale Single-Cell Data
- npj Digital Medicine, 2026 -- Developing a Speech-Driven Digital Biomarker for Cognitive Decline: Utilizing Speech as an Indicator for Cognitive Evaluation
- MDSpire News, 2026 -- Speech Changes Linked to Parkinson’s Disease Brain Asymmetry
- JAMA Neurology, 2026 -- Utilizing Automated Speech Analysis to Distinguish Clinical, Anatomical, and Pathological Subtypes of Primary Progressive Aphasia
- Frontiers, 2026 -- The 2024 NIA-AA biological definition of Alzheimer’s disease: linking biomarkers to clinical practice
- PMC, 2026 -- Diagnostic utility of speech-based biomarkers in mild cognitive impairment: a systematic review and meta-analysis
- PMC, 2026 -- Speech clocks decode dementia phenotypes, social exposome, and biological aging
- Frontiers | The 2024 NIA-AA biological definition of Alzheimer’s disease: linking biomarkers to clinical practice
- Diagnostic utility of speech-based biomarkers in mild cognitive impairment: a systematic review and meta-analysis - PMC
- Speech clocks decode dementia phenotypes, social exposome, and biological aging - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
